Medication info

Glitina Tablet 5 mg (Linagliptin)

Prescription medicationTabletExpired
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
Red circular film-coated tablet with a convex shape on both sides and sharp edges.
Packaging
30 tablets/PTP [10 tablets/PTP x 3]
Approval status
Expired

MFDS item code 201907236 · Approved 2019.10.15

This product's status changed to Expired on 2024.10.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this drug is 5mg once daily. It may be administered with or without food. When used in combination with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin or the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with Type 2 diabetes
View approved original text

This medication is used alongside diet and exercise to improve blood sugar control in patients with Type 2 diabetes. It can be administered alone to patients starting treatment, and if blood sugar control is inadequate with monotherapy, it can be combined with other drugs such as metformin. Additionally, this medication is added when treatments relying on sulfonylureas, insulin, or empagliflozin are insufficient to enhance blood sugar control. This flexibility allows for effective management of blood sugar in various treatment scenarios. As a result, this medication is used to enhance blood sugar control.

Dosage and Administration

Adult dosage

The recommended dose of this drug is 5mg once daily. It may be administered with or without food. When used in combination with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin or the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Precautions

This medication should not be used in patients who are allergic to this drug's active ingredient or other ingredients. It should not be administered to patients with Type 1 diabetes or diabetic ketoacidosis. Caution is required when used with medications that can cause hypoglycemia, such as insulin or sulfonylureas, as the risk of hypoglycemia may increase. This medication is not recommended for patients with heart failure, especially those with severe heart failure, and caution should be exercised in mild heart failure patients. If symptoms of acute pancreatitis, such as severe abdominal pain, occur during treatment with this medication, discontinue it immediately and consult a healthcare professional. A skin condition called bullous pemphigoid may occur, so any blisters or skin irritation should be reported to a doctor immediately. This medication may cause adverse reactions such as hypoglycemia, urticaria, rash, constipation, oral ulcers; if any abnormal symptoms arise, consult a healthcare provider. Use of this medication is not recommended during pregnancy or breastfeeding, and nursing mothers should exercise caution when taking it. The safety and efficacy of this medication have not been established for children under 10 years, so its use is not recommended in this age group. Elderly patients may use it without special dosage adjustments, but they should be attentive to adverse reactions while taking it. It can also be administered to patients with impaired kidney or liver function without dosage adjustments, but regular monitoring of their condition is advisable. In cases of overdose, remove any unabsorbed medication from the gastrointestinal tract and observe symptoms; appropriate treatment should be provided if necessary. Store out of reach of children and do not transfer to other containers for safety.

Side effects

  • Hypoglycemia
  • nasopharyngitis
  • hypersensitivity
  • angioedema
  • urticaria
  • hypertriglyceridemia
  • hyperlipidemia
  • cough
  • pancreatitis
  • constipation
Show 137 more
  • oral ulcer
  • rash
  • pemphigoid-like lesions
  • severe and disabling arthralgia
  • rhabdomyolysis
  • weight gain
  • increased lipase
  • increased amylase
  • dyspepsia
  • edema
  • facial edema
  • peripheral edema
  • weight loss
  • increased appetite
  • constipation
  • upper abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • shingles
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disturbance
  • Alzheimer’s disease dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • cholelithiasis
  • dizziness
  • kidney transplant failure
  • anemia
  • nausea
  • diarrhea
  • vomiting
  • gastroesophageal reflux disease
  • gastritis
  • viral upper respiratory tract infection
  • upper respiratory infection
  • gastroenteritis
  • vertigo
  • sensory deficit
  • chest discomfort
  • asthenia
  • nosebleed
  • oropharyngeal pain
  • speech disorders
  • allergic rhinitis
  • exercise-induced dyspnea
  • productive cough
  • runny nose
  • lung mass
  • arthralgia
  • osteoporosis
  • arthropathy
  • musculoskeletal discomfort
  • myositis
  • myalgia
  • soft tissue mass
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • increased serum triglycerides
  • increased urine albumin/creatinine ratio
  • positive urine leukocytes
  • decreased hemoglobin
  • increased serum potassium
  • increased serum creatinine
  • increased serum creatine phosphokinase
  • increased ALT
  • male-pattern baldness
  • diabetic foot complications
  • hyperhidrosis
  • hair loss
  • dermatitis
  • anxiety
  • affective disorder
  • insomnia
  • depression
  • contusion
  • bone contusion
  • concussion
  • arm fracture
  • hand fracture
  • laceration
  • palpitations
  • dry eye
  • glaucoma
  • cataract
  • ocular discomfort
  • allergic conjunctivitis
  • polyuria
  • proteinuria
  • stress urinary incontinence
  • hematuria
  • hypotension
  • flushing
  • hepatic steatosis
  • hearing loss
  • erectile dysfunction
  • thyroid goiter
  • pruritus
  • hypertension
  • benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1°C and 30°C. Proper storage will help keep the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Red circular film-coated tablet with a convex shape on both sides and sharp edges.

Package unit

30 tablets/PTP [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.